The effects of furosemide on kidney damage in acute kidney injury rat models

The most frequent cause of acute kidney injury (AKI) is ischemia reperfusion injuries that causes inflammation. Furosemide is still used in AKI’s therapy. The advantages and disadvantages of furosemide in AKI remain controversial. The aim of the study was to investigate the effect of furosemide on k...

Full description

Bibliographic Details
Main Authors: Afifah Afifah, . Ngatidjan, Nur Arfian
Format: Article
Language:English
Published: Universitas Gadjah Mada 2018-11-01
Series:Journal of the Medical Sciences
Subjects:
Online Access:https://jurnal.ugm.ac.id/bik/article/view/18083
Description
Summary:The most frequent cause of acute kidney injury (AKI) is ischemia reperfusion injuries that causes inflammation. Furosemide is still used in AKI’s therapy. The advantages and disadvantages of furosemide in AKI remain controversial. The aim of the study was to investigate the effect of furosemide on kidney damage in AKI rat models. Twenty-five male (2-3 months old) Sprague-Dawley rats were divided into 5 groups; sham operation (SO, n=5), ischemic-reperfusion (IR, n=5), IR+furosemide 3.6 mg/kgBW (IR+F1, n=5), IR+furosemide 7.2 mg/kgBW (IR+F2, n=5), and IR+furosemide 14.4 mg/kgBW (IR+F3, n=5). Abdominal surgery was performed under ketamine anesthesia to produce ischemic reperfusion (IR) by mean of renal artery clamping for 45 min. Urine output, serum creatinine level, tubular injury score, and TLR4 gene expression were examined to investigate kidney damage. Periodic acid-schiff (PAS) staining was measured to examine kidney tubular injury. Data were analyzed using One-Way ANOVA and Kruskal- Wallis test with significance level of p<0.05. AKI rat models which were given 3.6 and 7.2 mg/kgBW of furosemide (0.014±0.001 mL/min; and 0.012±0.007) showed higher (p>0.05) creatinine clearance compared to IR (0.009±0.003) while administration of 14.4 mg/kgBW furosemide (0.009±0.004) denoted equal creatinine clearance to IR (p>0,05). Kidney tubular injury score of 3.6 mg/kgBW furosemide (2.89±0.13) was lower (p>0.05) than IR (3.26±0.19) whereas 7.2 mg/kgBW and 14.4 mg/kgBW furosemide (3.55±0.26; 3.83±0.19) were higher (p<0.05) than IR. Administration of 3.6 mg/kgBW furosemide (0.99±0.08) indicated lower (p<0.05) TLR4 gene expression than IR (1.20±0.08) whilst 7.2 mg/kgBW furosemide (1.23±0.13) was not-significantly higher (p>0.05) and 14.4 mg/ kgBW furosemide (1.63±0.12) was significantly higher (p<0.05) than IR. In conclusion, administration of 3.6 mg/kgBW furosemide reduces kidney damage in AKI rat models while higher dosages (7.2 mg/kgBW and 14.4 mg/kgBW) increase kidney damage.
ISSN:0126-1312
2356-3931